Stay updated with breaking news from Michael Erman Editing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pfizer said on Tuesday its respiratory syncytial virus vaccine Abrysvo was well tolerated and generated an immune response in higher risk adults under the age of 60 similar to that in older adults,...
COVID-19 vaccine maker Novavax on Wednesday said it expects revenue this year to be flat or lower as it works to improve its commercial performance and pick up market share from much larger rivals,...
Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief...
Drugmakers including Pfizer , Sanofi and Takeda Pharmaceutical plan to raise prices in the United States on more than 500 unique drugs in early January, according to data analyzed by healthcare...
/cloudfront-us-east-2.images.arcpublishing.com/reuters/UBTXME2QKJLP3ICOKPX22TEGIA.jpg)
The U.S. government on Friday revised its guidance for its Medicare drug price negotiation process, allowing drug companies to publicly discuss the talks, but did not make major changes likely to convince drugmakers to end their suits seeking to halt the program.